IL6 and depressive symptom measurement: In RCTs for patients with major depression [54] or anxiety disorder [55], MBIs significantly reduced inflammatory cytokines including IL-6, suggesting the potential use of MBIs to improve depression- or anxiety-related low-grade inflammation.